September 2, 2014
Boehringer Ingelheim''s swine vaccine simplifies protection against Salmonella
Boehringer Ingelheim''s new swine vaccine protect against two of the most virulent types of Salmonella with a single, convenient oral dose administered by the drinking water or oral drench.
Boehringer Ingelheim Vetmedica, Inc. (BIVI)''s swine enteric vaccine Enterisol® Salmonella T/C is the only swine single-dose oral vaccine labelled as an aid in preventing disease due to Salmonella Choleraesuis and Salmonella Typhimurium when administered by drinking water.
Salmonella Choleraesuis is more invasive and can result in septicaemia, bronchopneumonia and death. Although there are no food safety concerns with S. Choleraesuis, it is more devastating in terms of mortality and lost production.
In comparison, Salmonella Typhimurium infection is more localised. It causes diarrhoea that can lead to dehydration and reduced performance. As S. Typhimurium poses a food safety risk to humans, producers should be especially vigilant in preventing this disease.
Enterisol Salmonella T/C is available in lyophilised (freeze-dried) or frozen formulations. It can be administered via the drinking water or oral drench to pigs as young as two weeks of age.
In addition, oral delivery of the vaccine results in less stress for pigs and greater convenience for workers by eliminating the need for injections. Oral vaccination through the drinking water may also improve worker safety and pork quality.